Drug therapy of postprandial hyperglycaemia.
- 1 January 1999
- journal article
- review article
- Published by Springer Science and Business Media LLC in Drugs
- Vol. 57 (1), 19-29
- https://doi.org/10.2165/00003495-199957010-00003
Abstract
No abstract availableKeywords
This publication has 83 references indexed in Scilit:
- Potential of ??-Glucosidase Inhibitors in Elderly Patients with Diabetes Mellitus and Impaired Glucose ToleranceDrugs & Aging, 1998
- Reduced Frequency of Severe Hypoglycemia and Coma in Well-Controlled IDDM Patients Treated With Insulin LisproDiabetes Care, 1997
- PROTECT interim results: a large multicenter study of patients with type II diabetesClinical Therapeutics, 1997
- Stimulation of Insulin Release by Non-Sulfonylurea Hypoglycemic Agents: The Meglitinide FamilyHormone and Metabolic Research, 1995
- AcarboseDrugs, 1993
- Postprandial triglyceridemia and carotid atherosclerosis in middle-aged subjects.Stroke, 1992
- Amylin concentrations and glucose controlThe Lancet, 1992
- Therapeutic Potentials of Acarbose as First-Line Drug in NIDDM Insufficiently Treated With Diet AloneDiabetes Care, 1991
- Plasma Insulin as Coronary Heart Disease Risk Factor: Relationship to other Risk Factors and Predictive Value during 9½‐year Follow‐up of the Helsinki Policemen Study PopulationActa Medica Scandinavica, 1985
- Increase in insulin response after treatment of overt maturity-onset diabetes is independent of the mode of treatmentDiabetologia, 1980